REFRACTORY JUVENILE MYELOMONOCYTIC LEUKEMIA

Clinical trials for REFRACTORY JUVENILE MYELOMONOCYTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY JUVENILE MYELOMONOCYTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY JUVENILE MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with Tough-to-Treat leukemia

Disease control Recruiting now

This early-stage study is testing a new drug, imetelstat, combined with two standard chemotherapy drugs (fludarabine and cytarabine) in children and young adults. It aims to find the safest dose and see if this combination can help control three types of aggressive blood cancers …

Matched conditions: REFRACTORY JUVENILE MYELOMONOCYTIC LEUKEMIA

Phase: PHASE1 • Sponsor: Children's Oncology Group • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

REFRACTORY JUVENILE MYELOMONOCYTIC LEUKEMIA

Get alerted when new REFRACTORY JUVENILE MYELOMONOCYTIC LEUKEMIA trials appear

New hope for kids with Tough-to-Treat leukemia